| Literature DB >> 35800646 |
Hidetaka Wakabayashi1, Keisuke Maeda2, Ryo Momosaki3, Yoji Kokura4, Yoshihiro Yoshimura5, Dai Fujiwara6, Shintaro Kosaka7, Norio Suzuki8.
Abstract
Diagnostic reasoning is the thought process used to arrive at a diagnosis based on symptoms, examination findings, and laboratory values. Diagnosis is categorized as nonanalytic reasoning (intuition) and analytic reasoning (analysis). Rehabilitation nutrition involves the diagnosis of nutritional disorders, sarcopenia, and excess or deficient nutrient intake. There is usually only one correct answer for the presence or absence of these. On the other hand, there may be no single correct answer for the causes of anorexia, weight loss, or sarcopenia, and analytical reasoning is required. In this case, diagnostic reasoning involves hypotheses. Simply using nutritional supplements without performing diagnostic reasoning about these causes is like prescribing antipyretic analgesics to a patient with a headache without diagnosing the cause of the headache. To maximize function and quality of life in rehabilitation nutrition, it is necessary to suspect the common causes of anorexia, weight loss, and sarcopenia in all cases.Entities:
Keywords: analytic reasoning; anorexia; nonanalytic reasoning; sarcopenia; weight loss
Year: 2022 PMID: 35800646 PMCID: PMC9249927 DOI: 10.1002/jgf2.549
Source DB: PubMed Journal: J Gen Fam Med ISSN: 2189-7948
The OPQRST mnemonic of weight loss
| Onset: “When did weight loss begin?” |
| Palliative & Provoke: “Has weight loss continued/improved?” |
| Quality & Quantity: “How much weight loss?” |
| Region: “Where did you lose weight?” |
| Symptoms: “What other symptoms do you have? Is there anorexia, nausea/vomiting, dysphagia, constipation, diarrhea, taste disorder, olfactory disorder, general fatigue, dyspnea, pain, fever, depression, anxiety, muscle weakness, or decreased ADLs?” |
| Time course: “How is the progress after weight loss?” |
Abbreviation: ADL, activities of daily living.
The meals on wheels mnemonic
| M: Medication |
| E: Emotional |
| A: Alcoholism, Abuse, Anorexia |
| L: Late‐life paranoia |
| S: Swallowing problems |
| O: Oral problems |
| N: Nosocomial infections, no money |
| W: Wandering |
| H: Hypothyroidism, hyperglycemia |
| E: Enteral problems |
| E: Eating problems |
| L: Low salt, low cholesterol |
| S: Stones, shopping problems, social problems, isolation |
Causes of weight loss in rehabilitation nutrition
|
|
| Malignancy |
| Gastrointestinal disease |
| Depression |
| Pharmaceutical (SGLT2 inhibitors, laxatives, NSAIDs, anti‐dementia drugs, antipsychotics, antidepressants, anticholinergics, anticancer drugs, diuretics, etc.) |
| Dysphagia (including disorders of oral function and environment) |
| Inappropriate nutritional management in hospitals and institutions |
| Dietary preferences in hospital/facilities (including swallowing adjusted diets) |
|
|
| Chronic heart failure |
| Chronic respiratory failure (e.g., chronic obstructive pulmonary disease) |
| Chronic renal failure |
| Diabetes (including excessive dietary restrictions) |
| Electrolyte abnormalities (e.g., hypercalcemia and hyponatremia) |
| Dementia, delirium, disorders of life rhythm |
| Taste and smell disorders |
| Eating, cooking, and shopping require assistance |
| Social problems (e.g., economic deprivation and isolation) |
| Aging |
|
|
| Chronic infectious diseases (e.g., infective endocarditis and tuberculosis) |
| Collagen and autoimmune diseases |
| Neuromuscular diseases (Parkinson disease, amyotrophic lateral sclerosis, etc.) |
| Adrenocortical insufficiency |
| Hyperthyroidism |
Abbreviations: NSAID, nonsteroidal anti‐inflammatory drug; SGLT2, sodium‐glucose cotransporter‐2.
The OPQRST mnemonic of anorexia
| Onset: “When did anorexia begin?” |
| Palliative & Provoke: “When does anorexia become stronger/weaker?” |
| Quality & Quantity: “How much anorexia? What can you eat?” |
| Region: “What do you think is wrong with your appetite?” |
| Symptoms: “What other symptoms do you have? Nausea/vomiting, pain, taste, smell?” |
| Time course: “What is the course of events after anorexia?” |
Causes of anorexia in rehabilitation nutrition
|
|
| Drug‐related (pregabalin, tramadol and other opioids, laxatives, NSAIDs, anti‐dementia drugs, antipsychotics, antidepressants, anticholinergics, steroids, antihistamines, anticancer drugs, bisphosphonates, Parkinson disease medications, muscle relaxants, diuretics, etc.) |
| Depression (including drug‐induced) |
| Dysphagia (including deterioration of oral function and environment, including drug‐related) |
| Dementia, delirium, disorders of life rhythm (including drug‐induced) |
| Gastrointestinal disorders (vomiting, diarrhea, constipation, functional dyspepsia, etc., including drug‐induced) |
| Hospital/facility food preferences (including adjusted swallowing diets) |
|
|
| Cachexia (malignancy, chronic heart failure, chronic respiratory failure, chronic renal failure, chronic infection, collagen disease, etc.) |
| Taste and smell disorders |
| Acute inflammation (e.g., acute infection) |
| Diabetes mellitus |
| Hypothyroidism |
| Aging (e.g., decreased activity, changes in eating, and exercise habits) |
Abbreviation: NSAID, nonsteroidal anti‐inflammatory drug.
Responses regarding case
| Respondents | What additional information would you like to collect to support your diagnostic reasoning regarding anorexia and weight loss? | What are the most likely causes of anorexia and weight loss (first, second, third)? | How should clinicians intervene for the first cause of anorexia and weight loss? | How should clinicians intervene for the second cause of anorexia and weight loss? | How should clinicians intervene for the third cause of anorexia and weight loss? | Please suggest nutrition goals after 1 month. | Please suggest rehabilitation goals after 1 month. | Please recommend nutrition intervention methods. | Please recommend rehabilitation intervention methods. |
|---|---|---|---|---|---|---|---|---|---|
| A |
Presence or absence of depression Presence and cause of feeding and swallowing difficulties (including denture maladjustment) Presence or absence of Parkinson's syndrome When was the drug used started? Preference for hospital food |
No. 1: Drug‐induced nausea (lubiprostone, tramadol) No. 2: Drug‐induced Parkinson's syndrome and dysphagia (sulpiride, risperidone) No. 3: Depression | Discontinue lubiprostone and tramadol. Use magnesium oxide and acetaminophen if constipation and pain are present. | Discontinue sulpiride and risperidone. If insomnia is present, use sleeping pills (e.g., Suvorexant). If nocturnal delirium develops, use yokukansan or yokukansan‐ka‐tinpihange. | Use antidepressants (e.g., mirtazapine). Prescribe occupational therapy and add psychological occupational therapy. | 1 kg weight gain if nausea, Parkinson's syndrome, and dysphagia improve after discontinuing lubiprostone, tramadol, sulpiride, and risperidone. | If nausea, parkinsonism, and dysphagia improve after discontinuing lubiprostone, tramadol, sulpiride, and risperidone, the patient will be able to walk short distances independently with T‐cane and have light assistance with bathing and stairs. | Discontinue lubiprostone, tramadol, sulpiride, and risperidone. Change to an adjusted swallowing diet that is appropriate for the patient's level of dysphagia and preferences. Add medium chain triglyceride oil and protein powder to whole gruel. Add oral nutritional supplements that are appropriate for the patient's level of dysphagia and preferences. | Discontinue lubiprostone, tramadol, sulpiride, and risperidone. Physical therapy should be light‐loaded to prevent disuse for the time being, and increased to include resistance training once nutritional intake improves. Prescribe occupational therapy and add psychological occupational therapy. Add swallowing therapy and provide swallowing function training. Denture adjustment by dentistry. |
| B |
Findings on extrapyramidal symptoms Patient's subjective view of food patterns When did you lose weight or food intake, along with medication history? CT or MRI of the brain Identification of inactive delirium |
No. 1: Drug‐induced anorexia No. 2: Inactive delirium No. 3: Vicious cycle of frailty |
Consider a dose reduction or withdrawal of tramadol and risperidone (possible cause of disorientation/inactive delirium). Consider withdrawal of sulpiride (possible extrapyramidal symptoms). Consider withdrawal of omeprazole (possible malabsorption/constipation). Consider changing lubiprostone (possible gastrointestinal symptoms such as abdominal bloating). Food fortification and oral nutritional supplements (Sip feed, Medication Pass), dietary appearance considerations. |
Provide care related to adjusting the living environment and diurnal rhythm adjustment. Consider reducing or withdrawing at‐risk medications. Food fortification and oral nutritional supplements (Sip feed, Medication Pass), dietary appearance considerations. |
Food fortification and oral nutritional supplements (Sip feed, Medication Pass), and dietary appearance considerations. Plan increases in physical activity and exercise in conjunction with increased nutritional intake. | Dietary intake of more than 1800 kcal/day, weight recovery of 2 kg, handgrip strength of 18 kg. |
One‐on‐one rehabilitation with a therapist for a caloric intake of at least 1800 kcal/day and at least 2 h/day. Barthel Index 80 points. |
Food fortification and oral nutritional supplements (Sip feed, Medication Pass), provide dietary appearance considerations. Provide 1900 kcal/day and 75 g protein. Conduct case conferences with rehabilitation staff and nurses to share information on activity levels. |
Increase or decrease activity levels to match nutritional intake. Individualized review of necessary activities in the home for rehabilitation intervention. Conduct a multidisciplinary case conference including a dietitian every 2 weeks. Share information on nutrition goals and rehabilitation goals. |
| C |
When to start each drug Characteristics of stools Abdominal characteristics (visual and palpation) Swallowing while eating Oral hygiene status |
No. 1: Drug‐induced anorexia No. 2: Drug‐induced dysphagia No. 3: Gastrointestinal tract diseases | Drug dose reduction (tramadol). | Drug reduction (sulpiride, risperidone). | Abdominal imaging examination. | Weight gain (about 2 kg). | Independent in walking and ADLs. | Consider snacking and oral nutritional supplements. | Adjust the amount of gait training according to nutritional status. |
| D |
Type of food for side dishes Availability of low‐sodium diets Oral condition (e.g., do dentures fit well?) Blood glucose level When to prescribe tramadol |
No. 1: Inappropriate food texture No. 2: Unnecessarily low‐sodium diets No. 3: Side effects of tramadol | Review whether the food texture is suitable. | Discontinue if on a low‐sodium diet. | Withdrawal or change of tramadol dose. | 1 kg weight gain. | Barthel Index gait 10 points. | Check the condition of the dentures and assess whether the diet texture is suitable. Offer a non‐sodium diet. If food intake does not increase, consider parenteral nutrition. | ADL training is the basis of the program, and if the patient is able (or has the prospect of being able) to consume the target energy level, resistance training and endurance training should be used to increase muscle mass. |
| E |
Presence of depression and/or delirium Oral condition (including denture fit) Presence or absence of gastrointestinal disease (including a close examination of constipation) Social and family environment Thyroid function |
No. 1: Drug‐induced No. 2: Environmental changes No. 3: Dementia and/or depression | Propose reduction or discontinuation of the causative drug, change to another drug, or nonpharmacological treatment. | Environmental adjustments: adjusting life rhythm, adjusting eating location (e.g., dining room instead of hospital room), encouraging getting out of bed during the day, meeting with family and friends. | Search for causes of dementia and depression and treat if possible. | 1 kg weight gain. | Indoor walking independence with walking aids. | Low‐dose, high‐energy diets, oral nutritional supplements, peripheral parenteral nutrition. | Gait training, muscle strengthening training of the whole body, and training for activities of daily living while ensuring that nutritional management is appropriate. |
| F |
Drug prescription history (how the current drug being used was prescribed) Presence and degree of depression Sleeping conditions at night Denture fit Dietary intake and preferences prior to illness |
No. 1: Drug‐induced (nausea with tramadol, hypersedation with risperidone, abdominal distention with lubiprostone, anorexia with eldecalcitol or omeprazole, etc.) No. 2: Decreased general endurance No. 3: Denture incompatibility | Tramadol and risperidone prescriptions should be discontinued. Consider the need for prescription adjustments for other medications. | Increase time away from bed outside of rehabilitation and meals. | Adjustment of dentures. | The patient should gain 2 kg (4.3 lb) in 1 month. The patient should be able to consume all of the provided regular diet. | Handgrip strength of 18 kg (AWGS sarcopenia threshold) or greater. Can walk with a cane in the ward with supervision. Independently defecate in the toilet. | Nutritional administration should be set up with an activity coefficient of 1.3, a stress coefficient of 1.0, and an energy accumulation of 500 kcal. The target energy intake should be 1720 kcal and 65 g protein (protein energy ratio 15%). Three meals should be provided and supplemented with additional oral nutritional supplements after rehabilitation and exercise. | Defecation is performed by guiding the patient to the toilet. Since improvement in nutritional status cannot be expected while the nutritional intake is low, resistance training should be avoided, and basic ADL training and walking training should be implemented. Once nutritional intake is sufficient, nutritional status is expected to improve, so the amount of gait training in rehabilitation should be increased, stair climbing training should be added, and resistance training (chair stand training) should be performed in the hospital ward. |
| G |
Pre‐admission diet Dietary preferences Hobbies Last defecation HDS‐R score details |
No. 1: Drug‐induced No. 2: Discrepancy in diet (texture and preference) No. 3: Iatrogenic malnutrition during hospitalization | Discontinuation of risperidone, tramadol, and lubiprsotone. | Providing meals that meet the preferences, oral environment, and assisting swallowing function. | Snacking with oral nutritional supplements, nutrient loading with a high‐energy diet such as power rice (added medium chain triglyceride oil and protein powder) or tube feeding. | Continuation of nutritional administration of at least 2000 kcal and 60 g of protein per day with a target body weight of 45 kg. | Extended standing retention time, target Barthel Index 70–80 points | The patient should be placed on a nasogastric tube, and enteral nutrition should be administered combined with oral intake. The patient should be transitioned to a high‐energy diet as she gains strength. | First, reduce supine time by using wheelchair rides and other activities during the day, and second, implement high‐load rehabilitation when the patient has increased endurance through extended rehabilitation time. |
| H |
Dietary intake prior to hospitalization Start date of each drug Preferences for meals served Eating and swallowing function (including denture fit) Stool characteristics (volume, color) |
No. 1: Malignancy No. 2: Drug‐induced No. 3: Dietary preference issues | Malignant tumor: After close examination by CT, endoscopy, fecal occult blood, tumor markers, etc., surgical and endoscopic treatment, chemotherapy and radiation therapy should be considered. If there is an obstruction of the gastrointestinal tract, we also aim to improve the obstruction. | Drug‐related: Discontinue the suspect drug or switch to a drug with the same effect that is less likely to cause anorexia and nausea. | Dietary preference issues: consider changing or adjusting the meal content and flavor to the individual's preferences. If the salt content is restricted for hypertension, consider relaxing the restriction. | Improve oral intake and prevent further weight loss. If oral intake is sufficient to meet energy requirements, the goal is to gain at least 1 kg. | Increase time for gait training with supervision; spend time in a sitting position outside of PT and meal times. | Assuming elimination of the cause and improvement. Energy requirement: basic energy consumption 941 kcal x activity coefficient 1.2 = 1129 kcal/day; current intake: calculated to be approximately 600 kcal/day. There is a high risk of refeeding syndrome (BMI < 18.5, weight loss of more than 10% within 3–6 months). Increase by 5–10 kcal/kg/day (approximately 200–400 kcal/day), and once the energy requirement is satisfied, increase by 1450–1700 kcal/day (daily energy accumulation 250 kcal to increase the dose up to 500 kcal/day). If improvement takes time or is difficult due to malignancy or other factors, add oral nutritional supplements concomitantly or in divided doses. | Until energy requirements are met, light‐load rehabilitation should be focused on lengthening sitting time, lengthening ADL time, etc. to prevent further muscle strength and ADL decline due to low activity. Once the energy requirement is met and energy accumulation can be added, gait training and low‐load resistance training should be increased. |